Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leishmaniasis: Current Status of Vaccine Development

1 Apr 2001

Abstract excerpt

Leishmaniae are obligatory intracellular protozoa in mononuclear phagocytes. They cause a spectrum of diseases, ranging in severity from spontaneously healing skin lesions to fatal visceral disease. Worldwide, there are 2 million new cases each year and 1/10 of the world's population is at risk of infection. To date, there are no vaccines against leishmaniasis and control measures rely on chemotherapy to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11292637
DOI: 10.1128/cmr.14.2.229-243.2001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leishmaniasis: Current Status of Vaccine DevelopmentPMID 11292637Read ↗

Live attenuated Leishmania vaccines: a potential strategic alternativeSemantic proximity Read ↗

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasisSemantic proximity Read ↗

Recent developments in leishmaniasisSemantic proximity Read ↗

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine CandidatesSemantic proximity Read ↗

Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated LeishmaniaSemantic proximity Read ↗

Leishmaniasis: Prevention, Parasite Detection and TreatmentSemantic proximity Read ↗

Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human LeishmaniasisSemantic proximity Read ↗

Post-Genomics and Vaccine Improvement for LeishmaniaSemantic proximity Read ↗

Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasiteSemantic proximity Read ↗

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.